Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Suzanne Reed, Carol Koro, Julia DiBello, Kerstin Becker, Anja Bauerfeind, Christian Franke & Klaas Heinemann. (2021) Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism. The European Journal of Contraception & Reproductive Health Care 26:6, pages 439-446.
Read now
Read now
Santiago Palacios, Enrico Colli & Pedro A. Regidor. (2021) Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study. The European Journal of Contraception & Reproductive Health Care 26:6, pages 454-461.
Read now
Read now
Luca Liban Mariani, Lorenzo Novara, Matteo Mancarella, Luca Fuso, Elisa Casula & Nicoletta Biglia. (2021) Estradiol/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis. Gynecological Endocrinology 37:7, pages 646-649.
Read now
Read now
Kristine Kollerøs Panton, Gustav Mikkelsen, Wenche Øiestad Irgens, Ann Kristin Hovde, Marte Wien Killingmo, Monja Airin Øien, Per Medbøe Thorsby & Arne Åsberg. (2019) New reference intervals for cortisol, cortisol binding globulin and free cortisol index in women using ethinyl estradiol. Scandinavian Journal of Clinical and Laboratory Investigation 79:5, pages 314-319.
Read now
Read now
Franca Fruzzetti & Angelo Cagnacci. (2018) Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?. Open Access Journal of Contraception 9, pages 75-79.
Read now
Read now
Ingrid Duijkers, Christine Klipping, Doris Heger-Mahn, Ghassan N. Fayad, Tara L. Frenkl, Sandra M. Cruz & Tjeerd Korver. (2018) Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing. The European Journal of Contraception & Reproductive Health Care 23:4, pages 245-254.
Read now
Read now
Michelle Yagnatovsky, Amos Z Dai, Michael Zacchilli & Laith M Jazrawi. (2018) Acute pulmonary embolism after arthroscopic glenoid labral repair and subacromial decompression: case report and review of the literature. The Physician and Sportsmedicine 46:1, pages 135-138.
Read now
Read now
Manuela Neri, Maria Elena Malune, Valentina Corda, Bruno Piras, Pierina Zedda, Monica Pilloni, Maria Paola Orani, Valerio Vallerino, Gian Benedetto Melis & Anna Maria Paoletti. (2017) Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC). Gynecological Endocrinology 33:12, pages 958-962.
Read now
Read now
Manuela Farris, Carlo Bastianelli, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis. Expert Review of Clinical Pharmacology 10:10, pages 1129-1144.
Read now
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2017) Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?. The European Journal of Contraception & Reproductive Health Care 22:4, pages 245-246.
Read now
Read now
Angelo Cagnacci. (2017) Hormonal contraception: venous and arterial disease. The European Journal of Contraception & Reproductive Health Care 22:3, pages 191-199.
Read now
Read now
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Review of Clinical Pharmacology 10:3, pages 315-326.
Read now
Read now
Giovanni Grandi, Antonella Napolitano & Angelo Cagnacci. (2016) Metabolic impact of combined hormonal contraceptives containing estradiol. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 779-787.
Read now
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Marie Mawet, Catherine Maillard, Christine Klipping, Yvette Zimmerman, Jean-Michel Foidart & Herjan J.T. Coelingh Bennink. (2015) Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. The European Journal of Contraception & Reproductive Health Care 20:6, pages 463-475.
Read now
Read now
Manuel Luque-Ramírez & Héctor Francisco Escobar-Morreale. (2015) Targets to treat androgen excess in polycystic ovary syndrome. Expert Opinion on Therapeutic Targets 19:11, pages 1545-1560.
Read now
Read now
Giovanni Grandi, Antonella Napolitano, Anjeza Xholli, Alessandra Tirelli, Costantino Di Carlo & Angelo Cagnacci. (2015) Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea. Gynecological Endocrinology 31:10, pages 774-778.
Read now
Read now
Iñaki Lete, Nathalie Chabbert-Buffet, Christian Jamin, Stefano Lello, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2015) Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European Journal of Contraception & Reproductive Health Care 20:5, pages 329-343.
Read now
Read now
Regine Sitruk-Ware & Anita Nath. (2015) Applying emerging science to contraception research: implications for the clinic. Expert Review of Endocrinology & Metabolism 10:1, pages 115-126.
Read now
Read now
Kai J. Buhling, Lisa Klovekorn, Benita Daniels, Friederike S. G. Studnitz, Christine Eulenburg & Alfred O. Mueck. (2014) Contraceptive counselling and self-prescription of contraceptives of German gynaecologists: Results of a nationwide survey. The European Journal of Contraception & Reproductive Health Care 19:6, pages 448-456.
Read now
Read now
Anne Burke. (2013) Nomegestrol acetate-17b-estradiol for oral contraception. Patient Preference and Adherence 7, pages 607-619.
Read now
Read now
Jeffrey T Jensen, Johannes Bitzer & Marco Serrani. (2013) Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol. Open Access Journal of Contraception 4, pages 39-50.
Read now
Read now
Nathalie Chabbert-Buffet, Jan Gerris, Christian Jamin, Stefano Lello, Inaki Lete, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2013) Toward a new concept of “natural balance” in oral estroprogestin contraception. Gynecological Endocrinology 29:10, pages 891-896.
Read now
Read now
Yvette Zimmerman, Wout Wouters & Herjan J. T. Coelingh Bennink. (2013) The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone. The European Journal of Contraception & Reproductive Health Care 18:3, pages 206-214.
Read now
Read now
Ulla M. Ågren, Marjatta Anttila, Kristiina Mäenpää-Liukko, Maija-Liisa Rantala, Hilkka Rautiainen, Werner F. Sommer & Ellen Mommers. (2011) Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. The European Journal of Contraception & Reproductive Health Care 16:6, pages 458-467.
Read now
Read now
Diana Mansour, Carole Verhoeven, Werner Sommer, Edith Weisberg, Surasak Taneepanichskul, Gian Benedetto Melis, Inger Sundström-Poromaa & Tjeerd Korver. (2011) Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. The European Journal of Contraception & Reproductive Health Care 16:6, pages 430-443.
Read now
Read now
Articles from other publishers (62)
Ömer Özcan, Wendy P.J. den Elzen, Jacquelien J. Hillebrand, Martin den Heijer, Laura L. van Loendersloot, Johan Fischer, Henrike Hamer, Robert de Jonge & Annemieke C. Heijboer. (2024) The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review. Clinical Chemistry and Laboratory Medicine (CCLM) 62:1, pages 18-40.
Crossref
Crossref
Andrea Flores-Rodriguez, Fernando Diaz Gonzalez-Colmenero, Mariana Garcia-Leal, Melissa Saenz-Flores, Erick Burciaga-Jimenez, Jorge A Zuñiga-Hernandez, Neri A Alvarez-Villalobos, Rene Rodríguez-Guajardo, Felipe A Morales-Martinez, Luis H Sordia-Hernandez & Rene Rodriguez-Gutierrez. (2023) Harms of third- and fourth-generation combined oral contraceptives in premenopausal women: A systematic review and meta-analysis. Journal of Investigative Medicine 71:8, pages 871-888.
Crossref
Crossref
Frank Z. Stanczyk, Sharon A. Winer, Jean-Michel Foidart & David F. Archer. (2023) Comparison of estrogenic components used for hormonal contraception. Contraception, pages 110310.
Crossref
Crossref
Veronika I. Komedina, Svetlana V. Yureneva & Sergey Yu. Kuznetsov. (2023) Effect of combined oral contraceptives with estrogen identical to natural estrogen on the metabolic profile and body composition in females during the menopausal transition. Gynecology 24:6, pages 487-493.
Crossref
Crossref
Annina H. Haverinen, Kaisu M. Luiro, Timea Szanto, Marika H. Kangasniemi, Leena Hiltunen, Susanna Sainio, Terhi T. Piltonen, Riitta Lassila, Juha S. Tapanainen & Oskari Heikinheimo. (2022) Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial. Acta Obstetricia et Gynecologica Scandinavica 101:10, pages 1102-1111.
Crossref
Crossref
Oskari Heikinheimo, Elena Toffol, Timo Partonen, Anna But, Antti Latvala & Jari Haukka. (2022) Systemic hormonal contraception and risk of venous thromboembolism. Acta Obstetricia et Gynecologica Scandinavica 101:8, pages 846-855.
Crossref
Crossref
Laure Morimont, Hélène Haguet, Jean-Michel Dogné, Ulysse Gaspard & Jonathan Douxfils. (2021) Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology 12.
Crossref
Crossref
Ingrid Duijkers, Christine Klipping, Virginie Kinet, Maud Jost, Adriana Bastidas & Jean-Michel Foidart. (2021) Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function. Contraception 103:6, pages 386-393.
Crossref
Crossref
Christine Klipping, Ingrid Duijkers, Marie Mawet, Catherine Maillard, Adriana Bastidas, Maud Jost & Jean-Michel Foidart. (2021) Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception 103:4, pages 213-221.
Crossref
Crossref
Motoi Sugimura. 2021. New Insights Into Metabolic Syndrome. New Insights Into Metabolic Syndrome.
Angelo Cagnacci & Anna Biasioli. 2021. Female and Male Contraception. Female and Male Contraception
299
317
.
Jonathan Douxfils, Christine Klipping, Ingrid Duijkers, Virginie Kinet, Marie Mawet, Catherine Maillard, Maud Jost, Jan Rosing & Jean-Michel Foidart. (2020) Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception 102:6, pages 396-402.
Crossref
Crossref
Deeksha Khialani, Frits Rosendaal & Astrid van Hylckama Vlieg. (2020) Hormonal Contraceptives and the Risk of Venous Thrombosis. Seminars in Thrombosis and Hemostasis 46:08, pages 865-871.
Crossref
Crossref
Jonathan Douxfils, Laure Morimont & Céline Bouvy. (2020) Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Seminars in Thrombosis and Hemostasis 46:08, pages 872-886.
Crossref
Crossref
Laure Morimont, Céline Bouvy, Anne‐Sophie Delvigne, Jean‐Michel Dogné & Jonathan Douxfils. (2020) Proof of concept of a new scale for the harmonization and the standardization of the ETP‐based APC resistance. Journal of Thrombosis and Haemostasis 18:4, pages 895-904.
Crossref
Crossref
Eric Amenyogbe, Gang Chen, Zhongliang Wang, Xiaoying Lu, Mingde Lin & Ai Ying Lin. (2020) A Review on Sex Steroid Hormone Estrogen Receptors in Mammals and Fish. International Journal of Endocrinology 2020, pages 1-9.
Crossref
Crossref
Alexandra Ycaza Herrera, Sophia Faude, Shawn E. Nielsen, Mallory Locke & Mara Mather. (2019) Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release. Neurobiology of Stress 10, pages 100151.
Crossref
Crossref
I. V. Kuznetsova. (2019) Individual choice of hormonal contraceptive. Medical alphabet 1:1, pages 6-14.
Crossref
Crossref
. (2019) FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception. BMJ Sexual & Reproductive Health 45:Suppl 1, pages 1-93.
Crossref
Crossref
Jason Freed & Kenneth A. Bauer. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
242
265
.
G. Plu-Bureau, E. Sabbagh & J. Hugon-Rodin. (2018) Contraception hormonale et risque vasculaire. RPC Contraception CNGOF. Gynécologie Obstétrique Fertilité & Sénologie 46:12, pages 823-833.
Crossref
Crossref
Maximilian Franz. (2018) Für (fast) jede Frau die passende Verhütung. gynäkologie + geburtshilfe 23:5, pages 28-33.
Crossref
Crossref
Yifan Jiang & Weijie Tian. (2017) The effects of progesterones on blood lipids in hormone replacement therapy. Lipids in Health and Disease 16:1.
Crossref
Crossref
Jeffrey T Jensen, Ilana B Addis, Jon D Hennebold & Randy L Bogan. (2017) Ovarian Lipid Metabolism Modulates Circulating Lipids in Premenopausal Women. The Journal of Clinical Endocrinology & Metabolism 102:9, pages 3138-3145.
Crossref
Crossref
Michael L James, Thomas Christianson, Daniel Woo & Nicolas Kam King Kon. (2017) Gonadal hormone regulation as therapeutic strategy after acute intracerebral hemorrhage. Proceedings of Singapore Healthcare 26:3, pages 139-143.
Crossref
Crossref
Salvatore CarusoStefano CianciMaria CariolaValentina FavaSalvatore Di PasquaAntonio Cianci. (2017)
Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17
β
-Estradiol
. Journal of Women's Health 26:7, pages 728-734.
Crossref
Crossref
Tássia Callai, Francieli Daronco, Nicolas Lauxen Konrad, Jéssica Francine Wichmann, Felipe Costa & Sérgio Henrique Prezzi. (2017) Tabagismo e uso de anticoncepcionais orais relacionados a fenômenos tromboembólicos: relato de caso e revisão de literatura. Reprodução & Climatério 32:2, pages 138-144.
Crossref
Crossref
Diana Mansour, Carolyn Westhoff, Uma Kher & Tjeerd Korver. (2017) Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17?-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women. Contraception 95:4, pages 390-397.
Crossref
Crossref
G. B. Dikke. (2016) How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners. Medical Council:2, pages 10-13.
Crossref
Crossref
Regine Sitruk-Ware. (2016) Hormonal contraception and thrombosis. Fertility and Sterility 106:6, pages 1289-1294.
Crossref
Crossref
Remco R. Berendsen, Rob C. Lindeman, Merel Boom, Leon P. H. J. Aarts, Eveline L. A. van Dorp & Luc J. Teppema. (2016) Erythropoietin does not have effects on the ventilatory and pulmonary vascular response to acute hypoxia in men and women. Experimental Physiology 101:9, pages 1230-1240.
Crossref
Crossref
Paul L. Wood & Dvora Bauman. (2015) Gynaecological issues affecting the obese adolescent. Best Practice & Research Clinical Obstetrics & Gynaecology 29:4, pages 453-465.
Crossref
Crossref
Justine Hugon-Rodin, Anne Gompel & Geneviève Plu-Bureau. (2014) MECHANISMS IN ENDOCRINOLOGY: Epidemiology of hormonal contraceptives-related venous thromboembolism. European Journal of Endocrinology 171:6, pages R221-R230.
Crossref
Crossref
Giovanni Grandi, Anjeza Xholli, Antonella Napolitano, Ilaria Piacenti, Manuela Bellafronte & Angelo Cagnacci. (2014) Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol. Contraception 90:5, pages 529-534.
Crossref
Crossref
Arrigo F. G. Cicero, Alessandra Reggi, Angelo Parini, Martino Morbini, Martina Rosticci, Elisa Grandi & Claudio Borghi. (2014) Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia. High Blood Pressure & Cardiovascular Prevention 21:3, pages 221-226.
Crossref
Crossref
. (2014) ?Zoely: a new combined oral contraceptive. Drug and Therapeutics Bulletin 52:8, pages 90-93.
Crossref
Crossref
Katrien Wierckx, Eva Van Caenegem, Thomas Schreiner, Ira Haraldsen, Alessandra Fisher, Kaatje Toye, Jean Marc Kaufman & Guy T'Sjoen. (2014) Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine 11:8, pages 1999-2011.
Crossref
Crossref
Laureen M Lopez, David A Grimes & Kenneth F Schulz. (2014) Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database of Systematic Reviews 2019:11.
Crossref
Crossref
Y. Zimmerman, M. J. C. Eijkemans, H. J. T. Coelingh Bennink, M. A. Blankenstein & B. C. J. M. Fauser. (2013) The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update 20:1, pages 76-105.
Crossref
Crossref
George K. Creatsas & Maria Creatsas. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
25
27
.
Rossella E. Nappi, Erica Terreno, Grazia Sances, Ellis Martini, Silvia Tonani, Valentina Santamaria, Cristina Tassorelli & Arsenio Spinillo. (2013) Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception 88:3, pages 369-375.
Crossref
Crossref
D. Foth, T. Römer & H.-J. Ahrendt. (2013) Hormonelle Kontrazeption mit östradiolhaltigen KombinationspräparatenHormonal contraception with estradiol-containing combined preparations. Gynäkologische Endokrinologie 11:3, pages 162-167.
Crossref
Crossref
David Crook. 2013. Contraception. Contraception
35
41
.
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Crossref
Frank Z. Stanczyk, David F. Archer & Bhagu R. Bhavnani. (2013) Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception 87:6, pages 706-727.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 20:2, pages 156-160.
Crossref
Crossref
Regine Sitruk-Ware, Anita Nath & Daniel R. MishellJr.Jr.. (2013) Contraception technology: past, present and future. Contraception 87:3, pages 319-330.
Crossref
Crossref
Genevieve Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin & Marianne Canonico. (2013) Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 25-34.
Crossref
Crossref
Regine Sitruk-Ware & Anita Nath. (2013) Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 13-24.
Crossref
Crossref
Sophie Christin-Maitre, Emmanuelle Laroche & Léopoldine Bricaire. (2013) A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate. Women's Health 9:1, pages 13-23.
Crossref
Crossref
G. Plu-Bureau. 2013. La Contraception en Pratique. La Contraception en Pratique
41
46
.
Katherine A. Lyseng-Williamson, Lily P. H. Yang & Greg L. Plosker. (2012) Nomegestrol acetate/estradiol: a guide to its use in oral contraception. Drugs & Therapy Perspectives 29:1, pages 1-6.
Crossref
Crossref
Uwe Fricke & Ulrich Schwabe. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013
47
120
.
Laureen M Lopez, Mario Chen, Deborah Hilgenberg, Julie Denison & Gretchen Stuart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
TERJE SØRDAL, PAUL GROB & CAROLE VERHOEVEN. (2012) Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia et Gynecologica Scandinavica 91:11, pages 1279-1285.
Crossref
Crossref
Lily P.H. Yang & Greg L. Plosker. (2012) Nomegestrol Acetate/Estradiol. Drugs 72:14, pages 1917-1928.
Crossref
Crossref
Hannelore Rott. (2012) Thrombotic risks of oral contraceptives. Current Opinion in Obstetrics & Gynecology 24:4, pages 235-240.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Cardiology 27:4, pages 441-454.
Crossref
Crossref
Carolyn Westhoff, Andrew M. Kaunitz, Tjeerd Korver, Werner Sommer, Luis Bahamondes, Philip Darney & Carole Verhoeven. (2012) Efficacy, Safety, and Tolerability of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate and 17β-Estradiol. Obstetrics & Gynecology 119:5, pages 989-999.
Crossref
Crossref
Xiangyan Ruan, Harald Seeger & Alfred O. Mueck. (2012) The pharmacology of nomegestrol acetate. Maturitas 71:4, pages 345-353.
Crossref
Crossref
Mohamed Hassan. (2012) Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2:2, pages 7.
Crossref
Crossref
Harry A van Diepen. (2012) Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative. Reproductive Biology and Endocrinology 10:1, pages 85.
Crossref
Crossref